Human T-cell responses to botulinum neurotoxin. Responses in vitro of lymphocytes from patients with cervical dystonia and/or other movement disorders treated with BoNT/A or BoNT/B-Reference-Cited by-同舟云学术

Human T-cell responses to botulinum neurotoxin. Responses in vitro of lymphocytes from patients with cervical dystonia and/or other movement disorders treated with BoNT/A or BoNT/B

Published:2011-12 Issue: Volume:240-241 Page:121-128
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Oshima Minako,Deitiker Philip R.,Jankovic Joseph,Duane Drake D.,Aoki K. Roger,Atassi M. Zouhair

Funder

Allergan

Welch Foundation

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,Immunology,Immunology and Allergy

Reference25 articles.

1. Basic immunological aspects of botulinum toxin therapy;Atassi;Mov. Disord.,2004

2. Submolecular recognition profiles in two mouse strains of non-protective and protective antibodies against botulinum neurotoxin A;Atassi;Mol. Immunol.,2005

3. Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay;Brin;Mov. Disord.,2008

4. Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia;Comella;Neurology,2005

5. Teaching tape for the motor section of the Toronto Western Spasmodic Torticollis Scale;Comella;Mov. Disord.,1997

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complexing Protein-Free Botulinum Neurotoxin A Formulations: Implications of Excipients for Immunogenicity;Toxins;2024-02-10

2. Impact of SARS-CoV-2 Vaccination or Infection on the Safety and Efficacy of Aesthetic Injections: A Systematic Review;Aesthetic Plastic Surgery;2024-02-01

3. Influence of COVID ‐19 mRNA vaccination on the efficacy and safety of Botulinum toxin type A injections;Journal of Cosmetic Dermatology;2022-08-08

4. Clinical Relevance of Neutralizing Antibodies in Botulinum Neurotoxin Type A;Botulinum Toxin - Recent Topics and Applications;2022-07-27

5. Clinical Implications of Difference in Antigenicity of Different Botulinum Neurotoxin Type A Preparations: Clinical Take-Home Messages from Our Research Pool and Literature;Toxins;2020-08-04